PDL Biopharma
PDLI
#8231
Rank
โ‚น26.80 B
Marketcap
โ‚น234.63
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -โ‚น9.63 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are โ‚น80.61 Million. In 2019 the company made an earning of -โ‚น5.93 Billion a decrease over its 2018 earnings that were of -โ‚น4.16 Billion.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-โ‚น9.63 Billion62.47%
2019-โ‚น5.93 Billion42.43%
2018-โ‚น4.16 Billion-121.38%
2017โ‚น19.44 B60.41%
2016โ‚น12.12 B-77.09%
2015โ‚น52.92 B3.09%
2014โ‚น51.34 B26.65%
2013โ‚น40.53 B19.82%
2012โ‚น33.83 B3.68%
2011โ‚น32.63 B77.17%
2010โ‚น18.41 B-35.29%
2009โ‚น28.46 B23.45%
2008โ‚น23.05 B-1751.42%
2007-โ‚น1.4 Billion-88.56%
2006-โ‚น12.21 Billion93.73%
2005-โ‚น6.3 Billion13.63%
2004-โ‚น5.55 Billion32.12%
2003-โ‚น4.2 Billion87.44%
2002-โ‚น2.24 Billion-302.45%
2001โ‚น1.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚น2.956 T-23,759.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น863.17 B-7,007.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.36 Billion-17.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น2.62 Billion-79.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-โ‚น14.77 Billion 18.19%๐Ÿ‡บ๐Ÿ‡ธ USA